United States

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AEL, DEN, FREQ

NEW YORK, Oct. 08, 2023 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

American Equity Investment Life Holding Company (NYSE: AEL)’s sale to Brookfield Reinsurance. As part of the agreement, each American Equity shareholder will receive $38.85 per share in cash and 0.49707 of a Brookfield Asset Management Ltd. class A limited voting share per share of American Equity. If you are an American Equity shareholder, click here to learn more about your rights and options.

Denbury Inc. (NYSE: DEN)’s sale to Exxon Mobil Corporation for $89.45 per share. If you are a Denbury shareholder, click here to learn more about your rights and options.

Frequency Therapeutics, Inc. (NASDAQ: FREQ)’s merger with Korro Bio, Inc. Pre-merger Frequency shareholders are expected to own approximately 8% of the combined company. If you are a Frequency shareholder, click here to learn more about your rights and options.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]  
https://www.halpersadeh.com

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment moderation is enabled. Your comment may take some time to appear.

Back to top button

Adblock detected

Please consider supporting us by disabling your ad blocker